Cann American Corp. (CNNA)
Cann American Corp. is an early-stage enterprise dedicated to developing specialized Cannabis sativa varieties designed for animal consumption. The company's strategic focus is on markets within various European Union countries. Established in 2004 and headquartered in Cloverdale, California, Cann American Corp. previously operated as Canamed4Pets, Inc. before officially rebranding in December 2019.
Sector: Drug Manufacturers - Specialty & Generic
Industry: Drug Manufacturers - Specialty & Generic
Cann American Corp.
OTC:CNNAHealthcare · Drug Manufacturers - Specialty & Generic
+25.00%$0.0050
CLOSED · Nov 13Prev close$0.0040+25.00%Close$0.0050
Mkt Cap$3.69M
EV-
Float377.22M
O/S737.84M
VOL108K sh
$ Vol$270
RVOL0.82×
Inst Own-
SI0.1%
Net Cash/Sh-
Dilution
MCap$3.69MFloat377.22MO/S737.84M
Dilution
No press releases found for CNNA.